A ground-breaking Canada-wide clinical trial has shown that a common anti-viral drug, ribavirin, can be beneficial in the treatment of cancer patients.
A ground-breaking Canada-wide clinical trial has shown that a common anti-viral drug, ribavirin, can be beneficial in the treatment of cancer patients.